Lumexa Imaging Holdings, Inc. (LMRI) Income Statement

NASDAQ: LMRIRevenue, profits, margins and EPS over 3 years.

LMRI 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+7.8%
$1.02B
2025 · hover or tap a bar for each year
2023: $935.9M2024: $948.9M (+1.4%)2025: $1.02B (+7.8%)
20232025
Gross profit+21.7%
$117.2M
2025 · hover or tap a bar for each year
2023: $99.0M2024: $96.3M (−2.7%)2025: $117.2M (+21.7%)
20232025
Operating income−51.6%
$26.7M
2025 · hover or tap a bar for each year
2023: $22.4M2024: $55.2M (+146.1%)2025: $26.7M (−51.6%)
20232025
Net income
−$47.1M
2025 · hover or tap a bar for each year
2023: −$122.2M2024: −$94.1M2025: −$47.1M
20232025
EPS (diluted)
−$0.02
2025 · hover or tap a bar for each year
2023: −$1.772024: −$1.002025: −$0.02
20232025
Net profit margin+5.3 pts
−4.6%
2025 · hover or tap a point for each year
2023: −13.1%2024: −9.9% (+3.1 pts)2025: −4.6% (+5.3 pts)
20232025

LMRI revenue and net income

RevenueNet incomeNet margin (right axis)

Where LMRI's revenue goes

2025
Revenue
$1.02B100.0%
Cost of revenue
−$905.9M−88.5%
Gross profit
$117.2M11.5%
Sales, general & admin
−$90.5M−8.8%
Operating income
$26.7M2.6%
Interest & other expense
−$59.0M−5.8%
Income taxes
−$14.9M−1.5%
Net income
−$47.1M−4.6%

Each bar shows an amount and its share of revenue. LMRI kept −4.6% of revenue as net income.

LMRI profit margins

GrossOperatingNet

LMRI growth rates

to 2025
1 year3 years5 years10 years
Revenue+7.8%———
Gross profit+21.7%———
Operating income−51.6%———
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

LMRI quarterly EPS vs estimates

Reported EPSAnalyst estimate

Lumexa Imaging beat the analyst EPS estimate in 1 of the last 4 quarters. Next report: November 11, 2026 (estimate $0.07).

LMRI income statement

Lumexa Imaging Holdings, Inc. annual income statement
202520242023
Revenue$1.02B$948.9M$935.9M
Cost of revenue$905.9M$852.6M$837.0M
Gross profit$117.2M$96.3M$99.0M
Sales, general & admin$90.5M$70.4M$55.2M
Total operating expenses$90.5M$41.0M$76.5M
Operating income$26.7M$55.2M$22.4M
Interest expense$118.5M$136.0M$141.7M
Income before taxes−$32.2M−$79.2M−$119.2M
Income taxes$14.9M$14.9M$3.0M
Net income−$47.1M−$94.1M−$122.2M
EBITDA$141.7M$114.0M$94.6M
EPS (diluted)−$0.02−$1.00−$1.77
Gross margin11.5%10.1%10.6%
Operating margin2.6%5.8%2.4%
Net margin−4.6%−9.9%−13.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in LMRI's financial statements (latest annual report filed March 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

LMRI financial results

In fiscal year 2025 (ended December 31, 2025), Lumexa Imaging reported revenue of $1.0 billion, up 7.8% from the year before. It had a net loss of $47.1 million, a net profit margin of −4.6%. Diluted earnings per share came to −$0.02.

See the LMRI stock overview for the latest quote and news, or the LMRI chart for price history and technical indicators.

LMRI income statement FAQ

What is Lumexa Imaging's annual revenue?

Lumexa Imaging reported total revenue of $1.0 billion for fiscal year 2025, which ended on December 31, 2025. That was up 7.8% from $948.9 million the previous year.

Is Lumexa Imaging profitable?

No. Lumexa Imaging reported a net loss of $47.1 million in fiscal 2025, a net profit margin of −4.6%; its operating margin was 2.6%.

What is Lumexa Imaging's gross margin?

Lumexa Imaging's gross margin was 11.5% in fiscal 2025: for every $100 of revenue, Lumexa Imaging kept $11 after the direct cost of its products and services.

What are Lumexa Imaging's earnings per share?

Lumexa Imaging earned $-0.02 per diluted share in fiscal 2025, compared with $-1.00 a year earlier.

When will Lumexa Imaging report its next earnings?

Lumexa Imaging is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.

When does Lumexa Imaging's fiscal year end?

Lumexa Imaging's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 30, 2026.

Medical Devices income statements